Insider Transactions in Q1 2021 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
130
+13.37%
|
-
|
|
Mar 31
2021
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
211
+0.22%
|
-
|
|
Mar 31
2021
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
195
+0.54%
|
-
|
|
Mar 31
2021
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
130
+0.23%
|
-
|
|
Mar 31
2021
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
300
+50.0%
|
-
|
|
Mar 31
2021
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
130
+0.0%
|
-
|
|
Mar 05
2021
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,750
+33.16%
|
$2,750
$1.39 P/Share
|
|
Mar 02
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,224
-1.04%
|
$110,160
$90.25 P/Share
|
|
Mar 02
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,619
-36.9%
|
$145,710
$90.25 P/Share
|
|
Mar 01
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
676
-0.57%
|
$62,192
$92.44 P/Share
|
|
Mar 01
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+1.58%
|
$1,900
$1.39 P/Share
|
|
Mar 01
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
881
-16.72%
|
$81,052
$92.44 P/Share
|
|
Mar 01
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+32.18%
|
$0
$0.93 P/Share
|
|
Feb 03
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,226
-1.04%
|
$117,696
$96.0 P/Share
|
|
Feb 03
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,619
-36.9%
|
$155,424
$96.0 P/Share
|
|
Feb 02
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
674
-0.57%
|
$64,704
$96.4 P/Share
|
|
Feb 02
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+1.58%
|
$1,900
$1.39 P/Share
|
|
Feb 02
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
881
-16.72%
|
$84,576
$96.4 P/Share
|
|
Feb 02
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+32.18%
|
$0
$0.93 P/Share
|
|
Jan 27
2021
|
Baker Bros. Advisors LP |
BUY
Exercise of conversion of derivative security
|
Indirect |
22,420
+1.11%
|
$627,760
$28.14 P/Share
|
|
Jan 11
2021
|
Michael D Loberg Director |
BUY
Bona fide gift
|
Indirect |
535
+20.0%
|
-
|
|
Jan 11
2021
|
Michael D Loberg Director |
SELL
Bona fide gift
|
Direct |
535
-100.0%
|
-
|
|
Jan 05
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,102
-0.94%
|
$87,058
$79.25 P/Share
|
|
Jan 05
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,503
-35.18%
|
$118,737
$79.33 P/Share
|
|
Jan 04
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
798
-0.67%
|
$61,446
$77.27 P/Share
|
|
Jan 04
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+1.58%
|
$1,900
$1.39 P/Share
|
|
Jan 04
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
997
-18.92%
|
$76,769
$77.27 P/Share
|
|
Jan 04
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+32.18%
|
$0
$0.93 P/Share
|
|
Jan 04
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
883
-46.57%
|
$77,704
$88.07 P/Share
|